Blue Owl Capital Corporation OBDC · NYSE
$10.36 +2.52% (+$0.26)
Summary
58 / 100 · Bulios Score
What speaks for it
- Revenue grew by 28% a year over the last 3 years.
- Out of every 100 USD of revenue, 20 USD is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- It pays out more in dividends than it earns: 301% of profit.
- It missed profit estimates 4 times in the last 8 quarters.
- Analysts expect revenue to fall by 6.8% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 17.8 USD for 1 USD of yearly profit. Over the last five years it was 9.2 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 31% a year over 5 years. Over the last 3 years it grew by 28% a year. For the next fiscal year analysts expect revenue to fall by 6.8%. Earnings per share grew by 1.7% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 32 USD
- Sales and administration 19 USD
- Taxes and other 28 USD
- Net profit 20 USD
Net profit, industry median (Asset Management) 35 USD
Out of every 100 USD of revenue, 20 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 16.90%
- Paid out of profit
- 301%
- Raised in a row
- 2 years
You receive $1.75 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 10
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $13 is 26% above today's price. 77% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.